Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Endometrial Neoplasms 6Lymphatic Metastasis 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Urologic Neoplasms 1Ureteral Neoplasms 1Recurrence 1Radiation Injuries 1Prostate Adenocarcinoma 1Postoperative Complications 1Ovarian Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Mixed Tumor, Mesodermal 1Melanoma 1Lymphedema 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Disease 1Cholangiocarcinoma 1

Interventions

Gemcitabine 9pembrolizumab 7Cisplatin 5enfortumab vedotin 4atezolizumab 4Trastuzumab 4Carboplatin 4Sunitinib 3Pemetrexed 3Mitomycin 3cabozantinib 2Water 2Sugammadex 2Standard of Care 2Saline Solution 2Paclitaxel 2Nivolumab 2Neostigmine 2Docetaxel 2Cetuximab 2Bevacizumab 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1vinflunine 1valrubicin 1tucatinib 1tislelizumab 1testosterone 17 beta-cypionate 1temsirolimus 1relatlimab 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Urologic Neoplasms × Lymph Node Excision × Clear all
NCT00751140 2017-05-30

Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
20 enrolled 7 charts
Genitourinary

Carcinoma, Transitional Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡